BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29235396)

  • 21. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.
    Solati Z; Jazayeri S; Tehrani-Doost M; Mahmoodianfard S; Gohari MR
    Nutr Neurosci; 2015 May; 18(4):162-8. PubMed ID: 24621065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression.
    Birkenhäger TK; Geldermans S; Van den Broek WW; van Beveren N; Fekkes D
    J Psychiatr Res; 2012 Mar; 46(3):285-9. PubMed ID: 22244515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic effect of serum BDNF levels in late-life depression: Moderated by childhood trauma and SSRI usage?
    Dimitriadis M; van den Brink RHS; Comijs HC; Oude Voshaar RC
    Psychoneuroendocrinology; 2019 May; 103():276-283. PubMed ID: 30771710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review.
    Talaee N; Azadvar S; Khodadadi S; Abbasi N; Asli-Pashaki ZN; Mirabzadeh Y; Kholghi G; Akhondzadeh S; Vaseghi S
    Eur J Clin Pharmacol; 2024 Jul; 80(7):983-1016. PubMed ID: 38558317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression.
    Serra-Millàs M; López-Vílchez I; Navarro V; Galán AM; Escolar G; Penadés R; Catalán R; Fañanás L; Arias B; Gastó C
    Psychopharmacology (Berl); 2011 Jul; 216(1):1-8. PubMed ID: 21308467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
    Umene-Nakano W; Yoshimura R; Ueda N; Suzuki A; Ikenouchi-Sugita A; Hori H; Otani K; Nakamura J
    J Psychopharmacol; 2010 Dec; 24(12):1764-71. PubMed ID: 19825907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.
    Martinotti G; Pettorruso M; De Berardis D; Varasano PA; Lucidi Pressanti G; De Remigis V; Valchera A; Ricci V; Di Nicola M; Janiri L; Biggio G; Di Giannantonio M
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26775293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.
    Molendijk ML; Bus BA; Spinhoven P; Penninx BW; Kenis G; Prickaerts J; Voshaar RC; Elzinga BM
    Mol Psychiatry; 2011 Nov; 16(11):1088-95. PubMed ID: 20856249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time.
    Bus BA; Molendijk ML; Tendolkar I; Penninx BW; Prickaerts J; Elzinga BM; Voshaar RC
    Mol Psychiatry; 2015 May; 20(5):602-8. PubMed ID: 25155878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
    Yoshimura R; Mitoma M; Sugita A; Hori H; Okamoto T; Umene W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1034-7. PubMed ID: 17459550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery.
    Nakazato M; Hashimoto K; Yoshimura K; Hashimoto T; Shimizu E; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1117-21. PubMed ID: 16753247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression?
    Vinberg M; Bukh JD; Bennike B; Kessing LV
    Psychiatry Res; 2013 Nov; 210(1):102-8. PubMed ID: 23684538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder.
    Ramesh V; Venkatesan V; Chellathai D; Silamban S
    Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between MKP-1, BDNF, and Gonadal Hormones with Depression on Perimenopausal Women.
    Hui LY; Wang YW; Zhou FL; Ma XC; Yan RZ; Zhang L; Wang QL; Yu X
    J Womens Health (Larchmt); 2016 Jan; 25(1):71-7. PubMed ID: 26176177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial.
    Matsuoka Y; Nishi D; Tanima Y; Itakura M; Kojima M; Hamazaki K; Noguchi H; Hamazaki T
    Transl Psychiatry; 2015 Jul; 5(7):e596. PubMed ID: 26151924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of brain-derived neurotrophic factor levels and depressive symptoms in young adults with acne vulgaris.
    He HY; Tian JL; Deng YQ; Xiong X; Xu Y; Liao YM; Fang J; Feng X; Ye X; Li CQ
    BMC Psychiatry; 2019 Jun; 19(1):193. PubMed ID: 31234814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.
    Munno D; Sterpone S; Fania S; Cappellin F; Mengozzi G; Saroldi M; Bechon E; Zullo G
    Panminerva Med; 2013 Dec; 55(4):377-84. PubMed ID: 24434345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment.
    Sagud M; Nikolac Perkovic M; Vuksan-Cusa B; Maravic A; Svob Strac D; Mihaljevic Peles A; Zivkovic M; Kusevic Z; Pivac N
    Psychopharmacology (Berl); 2016 Sep; 233(17):3259-67. PubMed ID: 27356518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of BDNF exon I region methylation in the treatment of depression with sertraline and its clinical diagnostic value.
    Xing Y; Sun T; Li G; Xu G; Cheng J; Gao S
    J Clin Lab Anal; 2021 Nov; 35(11):e23993. PubMed ID: 34528295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Brain-derived neurotrophic factor (BDNF) and mood disorder].
    Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Katsuki A; Hayashi K; Atake K; Ueda N; Nakamura J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov; 30(5-6):181-4. PubMed ID: 21226313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.